Study of off-label anti-cancer drugs in adults
Part of Cancer clinical trials.
This study follows adults with cancer who are receiving anti-cancer medicines that are being used “off-label” (not exactly as the usual label says). It aims to learn about how these treatments are used in real life and what outcomes people experience.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cancer diagnosis (from scans, tissue biopsy, or surgery findings).
- You are being treated with an anti-cancer drug used “off-label” in your care plan.
- You are at least 18 years old.
- You can sign and give written informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how anti-cancer (chemotherapy) drugs are used in adults age 65+ who have cancer. It may help doctors understand which treatments work best and are safest for older adults.
This study follows patients who take oral anticancer drugs and take part in a special monitoring program at Lyon-Sud hospital. It aims to understand what affects treatment safety and outcomes.
This is an observational study that follows adults with solid cancer who are receiving immune checkpoint inhibitor treatments. It aims to learn how these medicines are used and what outcomes may look like in everyday care.
This is an observational study that follows young adults with a confirmed cancer diagnosis to learn more about their experience and care. It does not test a new drug, but your information may help improve future cancer treatment and support.
This study collects evidence on personalized (“targeted”) cancer treatments for adults with rare cancers or rare tumor changes. If you may qualify, it may help make these treatments more widely available in the future by studying how well they work and how patients feel.
This study looks at people who are already taking long-term targeted cancer medicines. It may help researchers understand how these treatments work over time and whether there are ways to improve care.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.